Vanguard Group »

Sonnet Biotherapeutc Hldng I shares owned by Vanguard Group

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $26k 15k 1.74
2023-09-30 $42k 15k 2.87

More positions owned by Vanguard Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Sonnet Biotherapeutc Hldng I

Citadel Advisors
Vanguard Group
Advisor Group Holdings
Wells Fargo & Company
Jpmorgan Chase & Co
Private Wealth Management Group

View all funds holding Sonnet Biotherapeutc Hldng I